Registration — BROWN RUDNICK LLP for BOEHRINGER INGELHEIM PHARMACUTICALS INC (2007)

Firm

BROWN RUDNICK LLP

Client

BOEHRINGER INGELHEIM PHARMACUTICALS INC

Income

—

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Medicare perscription drug benefit, Medicaid reimbursement, tax and tariff, pedigree and importation, FDA drug safety, Biogenerics

Lobbyist	Covered position, as disclosed
DOYCE BOESCH New	N/A
JAMES BONHAM New	N/A
MARLENE ENGLISH New	N/A
ANNE FABRY New	N/A
MICHAEL LEWAN New	N/A
HENRY W MENN New	N/A
RUTH SMITH New	N/A

Health Issues HCR

Medicare perscription drug benefit, Medicaid reimbursement, tax and tariff, pedigree and importation, FDA drug safety, Biogenerics

Lobbyist	Covered position, as disclosed
DOYCE BOESCH New	N/A
JAMES BONHAM New	N/A
MARLENE ENGLISH New	N/A
ANNE FABRY New	N/A
MICHAEL LEWAN New	N/A
HENRY W MENN New	N/A
RUTH SMITH New	N/A

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

Entity	Country	Principal place of business	Ownership	Contribution declared
BOEHRINGER INGELHEIM GMBH	Germany	Germany	100.0%	—

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.